359 results
·
28ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Immunohistochemistry Assay, Antibody, Anaplastic Lymphoma Kinase
FDA Pre-Market Approval
FDA Class 3
·VENTANA ALK (D5F3) CDX ASSAY
Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)
FDA Pre-Market Approval
FDA Class 3
·DiaSorin ETI-EBK PLUS assay
Immunohistochemistry Assay, Antibody, Anaplastic Lymphoma Kinase
FDA Pre-Market Approval
FDA Class 3
·VENTANA ALK (D5F3) CDx Assay
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
FDA Pre-Market Approval
FDA Class 3
·FoundationOne CDx (F1CDx)
Stimulator, Neuromuscular, Lower Back Muscles, Totally Implanted For Pain Relief
FDA Pre-Market Approval
FDA Class 3
·Reactiv8 Implantable Neurostimulation System
Stimulator, Neuromuscular, Lower Back Muscles, Totally Implanted For Pain Relief
FDA Pre-Market Approval
FDA Class 3
·ReActiv8 Implantable Neurostimulation System
Stimulator, Neuromuscular, Lower Back Muscles, Totally Implanted For Pain Relief
FDA Pre-Market Approval
FDA Class 3
·ReActiv8 Implantable Neurostimulation System
Stimulator, Neuromuscular, Lower Back Muscles, Totally Implanted For Pain Relief
FDA Pre-Market Approval
FDA Class 3
·ReActiv8 Implantable Neurostimulation System
Stimulator, Neuromuscular, Lower Back Muscles, Totally Implanted For Pain Relief
FDA Pre-Market Approval
FDA Class 3
·Reactiv8 Implantable Neurostimulation System
Stimulator, Neuromuscular, Lower Back Muscles, Totally Implanted For Pain Relief
FDA Pre-Market Approval
FDA Class 3
·ReActiv8 Implantable Neurostimulation System
Stimulator, Neuromuscular, Lower Back Muscles, Totally Implanted For Pain Relief
FDA Pre-Market Approval
FDA Class 3
·ReActiv8 Implantable Neurostimulation System
Stimulator, Neuromuscular, Lower Back Muscles, Totally Implanted For Pain Relief
FDA Pre-Market Approval
FDA Class 3
·Reactiv8 Implantable Neurostimulation System
System, Test, Her-2/Neu, Nucleic Acid Or Serum
FDA Pre-Market Approval
FDA Class 3
·PATH VYSION HER-2 DNA PROBE KIT
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·URO VYSION BLADDER CANCER KIT
Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement
FDA Pre-Market Approval
FDA Class 3
·VYSIS ALK BREAK APART FISH PROBE KIT
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·URO VYSION BLADDER CANCER KIT
System, Test, Her-2/Neu, Nucleic Acid Or Serum
FDA Pre-Market Approval
FDA Class 3
·THE PATH VYSION HER-2 DNA PRODE KIT
Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement
FDA Pre-Market Approval
FDA Class 3
·VYSIS ALK BREAK APART FISH PROBE KIT
Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement
FDA Pre-Market Approval
FDA Class 3
·Vysis ALK Break Apart FISH Probe Kit
Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement
FDA Pre-Market Approval
FDA Class 3
·Vysis ALK Break Apart FISH Probe Kit